The CareVoice, a Shangai, China-based health insurtech platform, closed an eight figure USD Series A funding.
The amount of the deal was not disclosed.
The round was led by LUN Partners Group, and a global investment manager specializing in financial services. DNA Capital, a global healthcare fund, as well as returning investors SOSV and Artesian Capital, also joined the round.
The company intends to use the funds to:
– Invest in R&D and continuously upgrade the CareVoiceOS end-to-end digital healthcare and insurance experience,
– Expand its sales and customer success teams as well as international business development efforts, and
– Accelerate the launch of 10 new health insurance products, in partnership with insurers, focusing on health prevention and change of behavior.
Founded in Shanghai in 2014 by Sebastien Gaudin, CEO, The CareVoice provides a data-driven mobile-based SaaS solution that digitizes the healthcare and insurance journey. It has been adopted in Mainland China and Hong Kong by 15 local and international insurance companies, including Ping An and AXA.
Additionally, the company has recently released CareVoiceOSTM, a healthcare “Operating System” for insurers. The platform provides an end-to-end technology solution that insurers can use to design and bring more tailored insurance plans, while also tapping into an ecosystem of connected healthcare services.
As part of this Series A round, StartupCare, the recent venture launched by The CareVoice providing health benefits for entrepreneurs and their teams, has been spun off. It now has the financial means to accelerate further its uptake in Mainland China and Hong Kong.
The CareVoice completed the Chinaccelerator program in 2017 and the Ping An Cloud Accelerator program in 2018.